QNRX Quoin Pharmaceuticals, Ltd. - American Depositary Shares
$5,17
Kurs · Mai 19, 2026
Fundamentaldaten per Mai 7, 2026
52W-Spanne
$5–$42
1% of range
Analystenbewertung
BUY
8 analysts
Kursziel
$30
+475% upside
P/E (TTM)
—
ROE
-201.7%
Nettogewinnmarge
—
QNRX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$5.17
Marktkapitalisierung
$757M
P/E (TTM)
—
EPS (TTM)
—
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-201.7%
Verschuldungsgrad
—
52W-Spanne
$5 – $42
QNRX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
—
Freier Cashflow
—
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
QNRX
Peer-Median
P/B (K/B)
57.7
3.1
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
QNRX
Peer-Median
ROA
-87.6%
-71.8%
ROE
-201.7%
-102.0%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
QNRX
Peer-Median
Current Ratio (Liquiditätsgrad)
3.6
4.0
Quick Ratio
3.4
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
QNRX
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
QNRX
Peer-Median
QNRX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
8 Analysten
- Starker Kauf 2 25,0%
- Kauf 5 62,5%
- Halten 1 12,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
4 Analysten · 2026-05-20
Median
$32.50
Mittelwert
$29.75
← Unter allen Zielen
$5.17
Tief
$14.00
Hoch
$40.00
Median-Ziel
$32.50
+528,6%
Mittelwert-Ziel
$29.75
+475,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.93%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-1.77 | $-1.97 | 0.20% |
| 31. Dezember 2025 | $-1.50 | $-3.40 | 1.9% |
| 30. September 2025 | $-6.71 | $-5.08 | -1.6% |
| 30. Juni 2025 | $-6.28 | $-7.56 | 1.3% |
| 31. März 2025 | $-6.50 | $-6.19 | -0.31% |
| 31. Dezember 2024 | $-12.25 | $-16.42 | 4.2% |
Vergleich mit Konkurrenten Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| QNRX | $757M | — | — | — | -201.7% | — |
| NRSN | — | — | — | — | — | — |
| PLRZ | — | — | — | — | — | — |
| CMMB | — | — | — | — | — | — |
| EVGN | — | — | — | — | — | — |
| CLGN | — | — | — | — | — | — |
| GLMD | — | — | — | — | — | — |
| URGN | $1.13B | — | 21.4% | -139.8% | 154.4% | 88.7% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $10M | $4M | $3M | $3M | $2M | |
| SG&A Expense | $6M | $6M | $6M | $7M | $4M | |
| Other Non-op | $486.1K | $566.0K | $691.9K | $-123.8K | $-15M | |
| Pretax Income | $-16M | $-9M | · | · | · | |
| Net Income | $-16M | $-9M | $-9M | $-9M | $-21M |
Bilanz 19
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $4M | $2M | $3M | $7M | |
| Short-term Investments | $15M | $10M | · | · | · | |
| Prepaid Expense | $1M | $869.1K | $591.0K | $516.6K | $715.5K | |
| Current Assets | $20M | $15M | $11M | $13M | $8M | |
| Intangibles | $383.3K | $483.3K | $583.3K | $704.6K | $808.6K | |
| Total Assets | $20M | $16M | $12M | $14M | $9M | |
| Accounts Payable | $1M | $905.7K | $526.5K | $605.6K | $923.2K | |
| Accrued Liabilities | $3M | $2M | $1M | $1M | $2M | |
| Current Liabilities | $6M | $4M | $4M | $4M | $5M | |
| Other Non-current Liabilities | $2M | $2M | $3M | $4M | · | |
| Total Liabilities | $7M | $7M | $7M | $7M | $9M | |
| Common Stock | $0 | $0 | $0 | $0 | · | |
| Paid-in Capital | $84M | $64M | $52M | $48M | $32M | |
| Retained Earnings | $-71M | $-55M | $-46M | $-38M | $-28M | |
| Treasury Stock | · | · | · | $3M | $3M | |
| AOCI | $-613 | $55M | $46M | $38M | · | |
| Stockholders' Equity | $13M | $9M | $6M | $7M | $657.0K | |
| Liabilities + Equity | $20M | $16M | $12M | $14M | $9M | |
| Shares Outstanding | 52,441,360 | 8,948,164 | 987,220 | 403,887 | 55,913 |
Cashflow 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $764.0K | · | |
| Amort. of Intangibles | $100.0K | $100.0K | $104.0K | $104.0K | $104.0K | |
| Operating Cash Flow | $-14M | $-8M | $-8M | $-8M | $-6M | |
| Investing Cash Flow | $-4M | $-2M | $2M | $-10M | $-625.0K | |
| Stock Issued | $19M | $12M | · | · | · | |
| Net Stock Activity | $19M | · | · | · | · | |
| Financing Cash Flow | $18M | $11M | $5M | $14M | $14M | |
| Net Change in Cash | $194.8K | $1M | · | · | · |
Rentabilität 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -87.6% | -64.3% | -65.2% | -78.8% | · | |
| ROE | -201.7% | -122.4% | -132.8% | -113.2% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 3.6 | 3.2 | 3.8 | · | |
| Quick Ratio | 3.4 | 0.9 | 0.7 | 0.8 | · |
Bewertung (TTM) 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-16M | $-9M | $-9M | $-9M | · | |
| Market Cap | $757M | $204M | $169M | $14.45T | · | |
| P/B | 57.7 | 22.1 | 29.9 | 1951264.6 | · | |
| P / Tangible Book | 59.4 | 23.4 | 33.4 | 2156388.6 | · | |
| P / Cash Flow | -55.9 | -25.9 | -21.6 | -1704166.1 | · |
Gewinn- und Verlustrechnung 4
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $587.5K | $885.3K | $832.4K | $758.8K | $625.1K | $1M | $613.1K | |
| SG&A Expense | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | |
| Other Non-op | $133.5K | $172.1K | $71.8K | $97.2K | $145.0K | $93.8K | $178.1K | $163.1K | $131.0K | $167.8K | $198.5K | $153.1K | $172.5K | $85.0K | |
| Net Income | $-5M | $-4M | $-4M | $-4M | $-4M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M |
Bilanz 19
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $4M | $2M | $2M | $4M | $4M | $3M | $3M | $2M | $2M | $3M | $5M | $3M | $3M | |
| Short-term Investments | $11M | $15M | · | · | · | $10M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $1M | $602.7K | $688.9K | $944.1K | $869.1K | $190.5K | $650.7K | $574.9K | $591.0K | $159.9K | $234.2K | $398.9K | $516.6K | |
| Current Assets | $15M | $20M | $6M | $8M | $12M | $15M | $10M | $13M | $15M | $11M | $14M | $16M | $17M | $13M | |
| Intangibles | $358.3K | $383.3K | $408.3K | $433.3K | $458.3K | $483.3K | $508.3K | $533.3K | $558.3K | $583.3K | $626.5K | $652.5K | $678.5K | $704.6K | |
| Total Assets | $16M | $20M | $6M | $9M | $13M | $16M | $11M | $14M | $16M | $12M | $15M | $17M | $18M | $14M | |
| Accounts Payable | $2M | $1M | $2M | $873.7K | $644.1K | $905.7K | $222.6K | $819.7K | $358.5K | $526.5K | $240.0K | $707.9K | $281.1K | $605.6K | |
| Accrued Liabilities | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $3M | $2M | $2M | $1M | |
| Current Liabilities | $5M | $6M | $6M | $4M | $5M | $4M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $4M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | · | $4M | |
| Total Liabilities | $7M | $7M | $8M | $6M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $8M | $8M | $7M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $85M | $84M | $65M | $65M | $65M | $64M | $58M | $58M | $58M | $52M | $54M | $54M | $54M | $48M | |
| Retained Earnings | $-76M | $-71M | $-67M | $-63M | $-59M | $-55M | $-53M | $-51M | $-49M | $-46M | $-44M | $-42M | $-40M | $-38M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | $3M | |
| AOCI | $-159 | $-613 | · | $63M | $59M | · | $-53M | $50M | $48M | · | $44M | $42M | $40M | · | |
| Stockholders' Equity | $9M | $13M | $-1M | $3M | $6M | $9M | $5M | $7M | $9M | $6M | $7M | $9M | $11M | $7M | |
| Liabilities + Equity | $16M | $20M | $6M | $9M | $13M | $16M | $11M | $14M | $16M | $12M | $15M | $17M | $18M | $14M | |
| Shares Outstanding | 68,642,195 | 52,441,360 | 20,585,830 | 20,585,830 | 20,585,830 | 8,948,164 | 5,049,720 | 3,979,970 | 3,795,970 | 987,220 | 987,220 | 59,233,024,799 | 59,233,024,799 | 403,887 |
Cashflow 6
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $444.5K | $283.2K | $182.2K | $321.5K | $360.4K | $326.3K | $313.1K | $313.1K | $306.3K | $300.2K | $268.5K | $264.4K | $261.5K | $267.3K | |
| Amort. of Intangibles | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | |
| Operating Cash Flow | $-5M | $-5M | $-2M | $-4M | $-3M | $-2M | $-2M | $-2M | $-1M | $-3M | $-1M | $-2M | $-2M | $-2M | |
| Investing Cash Flow | $4M | $-11M | $3M | $2M | $3M | $-3M | $3M | $3M | $-4M | $3M | $821 | $3M | $-3M | $0 | |
| Financing Cash Flow | $56.0K | $18M | $-150.0K | $-150.0K | $23.0K | $6M | $-149.9K | $-136.3K | $5M | $-182.6K | $-275.0K | $-75.0K | $6M | $-446.9K | |
| Net Change in Cash | $-693.6K | · | · | · | $198.8K | · | · | · | · | · | · | · | · | · |
Rentabilität 2
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -34.9% | · | -44.3% | -32.2% | -26.2% | · | -41.3% | -13.6% | -13.5% | · | · | -25.2% | -28.2% | · | |
| ROE | -68.0% | · | -186.8% | -73.7% | -50.7% | · | -86.4% | -26.5% | -23.2% | · | · | -46.5% | -47.7% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | · | 1.0 | 2.0 | 2.6 | · | 3.0 | 3.3 | 3.6 | · | · | 3.6 | 4.2 | · | |
| Quick Ratio | 2.6 | · | 0.3 | 0.4 | 0.8 | · | 0.9 | 0.7 | 0.4 | · | · | 1.1 | 0.8 | · |
Bewertung (TTM) 5
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-16M | · | $-14M | $-12M | $-10M | · | $-9M | $-8M | $-9M | · | $-10M | $-10M | $-10M | · | |
| Market Cap | $453M | · | $148M | $190M | $161M | · | $87M | $81M | $126M | · | · | $12.44T | $11.84T | · | |
| P/B | 51.6 | · | -121.9 | 74.5 | 27.2 | · | 16.0 | 10.8 | 13.8 | · | · | 1371154.2 | 1084972.1 | · | |
| P / Tangible Book | 53.8 | · | · | 89.7 | 29.5 | · | 17.7 | 11.6 | 14.7 | · | · | 1477425.3 | 1156896.3 | · | |
| P / Cash Flow | -93.0 | · | · | · | -62.2 | · | · | · | -88.0 | · | · | · | -6780205.6 | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-16M | $-9M | $-9M | $-9M | $-21M |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 3.6 | 3.6 | 3.2 | 3.8 | — |
| Quick Ratio | 3.4 | 0.9 | 0.7 | 0.8 | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.